Tactile Medical
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Tactile Medical sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
Tactile Medical: 14 sponsored US clinical trials, 1 recruiting.
Tactile Medical sponsors 14 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Lymphedema; Surgical, with 1 trials.
Top-decile sponsor footprint
Tactile Medical ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
6 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (46.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
14 total, page 1 of 1
Evaluate Advanced Pneumatic Compression Device With Revised Compression Programming for Lymphedema Treatment
NCT07613931
A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema
NCT04797390
Determining Swallow Outcomes in Head & Neck Lymphedema Subjects Receiving Early Intervention With Pneumatic Compression
NCT04335981
Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.
NCT04432727
A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients
NCT04073823
CVR Registry Evaluating Flexitouch Plus and Conservative Care vs Conservative Care Only for Treatment of Lymphedema
NCT04116099
A Registry to Evaluate the Flexitouch System and Flexitouch Plus for Treatment of Head and Neck Lymphedema
NCT03558672
A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment
NCT03332160
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema
NCT02946021
VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging
NCT02680834
Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)
NCT02661646
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)
NCT02395302
Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort
NCT02015221
Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema
NCT01239160
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
What is open in the Tactile Medical pipeline
1 recruiting of 14 indexed (7% open); 6 completed (43%).
Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Lymphedema; Surgical (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Tactile Medical: open-pipeline peers nationwide
Peers matched on 14 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Tactile Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Carol Fabian, MD · 7% recruiting · 14 trials
- Celldex Therapeutics · 7% recruiting · 42 trials
- Kaiser Permanente · 7% recruiting · 294 trials
- Mannkind Corporation · 7% recruiting · 42 trials
Related
What to do with this Tactile Medical page
14 registered trials is a research-attention snapshot, not an endorsement of Tactile Medical or any single study.
- 1 of Tactile Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lymphedema; Surgical is the condition Tactile Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lymphedema; Surgical trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Tactile Medical pipeline card: 14 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.